Transplant Diagnostic Market

Transplant Diagnostic Market Overview

The global Transplant Diagnostic Market size was valued at USD 4.59 billion in 2024 and is predicted to reach USD 6.93 billion by 2034 with a CAGR of 7.1% from 2025-2030.

Transplant diagnostics market grows due to the rise in chronic disease that requires effective diagnostics tool to conduct better organ compatibility and ensure better patient outcome. However, high cost associated with advanced diagnostics tools slows down the overall growth of the market. On the contrary, advancement in technologies including artificial intelligence is anticipated to create future opportunity for the growth of the market. 

Additionally, the top players operating in the market are as Thermo Fisher Scientific and Care Dx among others are adopting various business strategies including product launch and partnership to maintain their market presence and expand their product offering. With the advancement in technologies including artificial intelligence the market is set for further revolution as these technologies will analyse large volumes of pathology data more accurately and quickly than traditional methods, and helps to identify early signs of rejection and optimize treatment plans.

Rising Chronic Diseases Worldwide Drives the Growth of the Market

The rising prevalence of chronic diseases such as chronic obstructive pulmonary diseases abbreviated as COPD, diabetes, and kidney disorders globally drives the demand for better treatment including transplantation. Transplantation of organ requires better diagnostic technologies to ensure better organ compatibility, significantly driving the growth of the market. According to the World Health Organization latest report published on September 2023, around 41 million people lose their life due to noncommunicable diseases each year. The surge in fatalities due to chronic conditions need effective diagnostic tools to save lives, thereby driving the market growth for transplant diagnostic industry.

Integration of Surgical Robots Boosts Market Growth

The integration of surgical robots in transplant procedures enhances surgical precision and reduces complications that leads to better patient outcomes. These advancement increases the transplant diagnostic market demand for specialized diagnostic tools to support robotic procedures driving the market growth. For instance, in October 2023, Mayo Clinic surgeons perform first robotic-assisted kidney transplant in Minnesota a state in the U.S., that lowers the risk of patients and avoid complications, such as infections and hernia. Moreover, in July 2024, a robotic assisted surgery for kidney was performed in UK on a child aged seven years. This growing reliance on robotics highlights the need for sophisticated diagnostic tools, fuelling the growth of the market. 

Ageing Population Fuels Market Growth

The burgeoning elderly population, combined with escalating incidences of age-related ailments such as chronic renal failure and chronic respiratory diseases, provides for an increase in demand for transplant operations. This increased demand for organ transplants also leads to greater demand for advanced diagnostic technologies, largening the market for their providers. 

The United Nations, in its report dated January 2023, has estimated that the global population of people aged 65 years and above is expected to double, from 761 million in 2021, approaching 1.6 billion by the year 2050. An alarming increase in the elderly population thus indicates an increase in demand for efficient transplant solutions and advanced diagnostic technologies.

High Cost Associated with Diagnostic Tool Hinders the Growth of the Market

The high costs of advanced diagnostic tools restrict market growth, particularly for healthcare providers with limited financial resources. The substantial initial investment and ongoing expenses create barriers, making it challenging for many facilities to adopt and maintain these technologies, thereby limiting access and widening healthcare disparities.  

Advancement in Technologies Creates Future Opportunity for the Market 

The advancement in technologies such as artificial intelligence (AI) empowered digital pathology is expected to create future opportunities for the market. AI can analyse large volumes of pathology data more accurately and quickly than traditional methods, and helps to identify early signs of rejection and optimize treatment plans.

Market Segmentations and Scope of the Study 

The transplant diagnostic market report is segmented on the basis of product type, technology, transplant type, distribution channel, application, end-user and region. Based on product type, the global market is segmented into transplant diagnostic instrument, transplant diagnostic software, transplant diagnostic reagent. On the basis of technology, the market is bifurcated into PCR-based molecular assays and sequencing-based molecular assays. On the basis of transplant type, the market is classified into solid organ transplantation, stem cell transplantation, soft tissue transplantation, bone marrow transplantation and other. 

On the basis of application, the market is bifurcated into diagnostic applications and research applications. On the basis of distribution channel, the market is divided into direct tender, retail sales and others. On the basis of end-user, the market is segmented into research laboratories and academic institutes, hospital and transplant centres, commercial service providers and others. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the dominant in transplant diagnostic market share and is expected to continue its dominance during the forecast period due to the rise in number of surgeries performed in the region. The surge in number of surgeries require effective diagnostics tool to minimize organ failure and ensure successful outcomes. According to a report by the United Network for Organ Sharing, organ transplantation procedures have exceeded 46,000 to make up its impact annually. The rise in organ transplants insist for more good diagnostic solutions to enhance surgical efficiency and patient care.

Moreover, the growing prevalence of chronic diseases in the region contributes to the expansion of the market. When chronic diseases such as heart disease, diabetes, and kidney disorders become common, the demand for organ transplants also rises. According to a report published by the Centers for Disease Control and Prevention, approximately 129 million people in the U.S. have one chronic disease. This surge of chronic conditions further increases the number of candidate patients for transplant screening development, further fuelling the growth of the market.

On the other hand, Asia-Pacific shows a steady rise in the transplant diagnostic market during the forecast period as this region is home to a large and rapidly aging population. With increasing life expectancy, the prevalence of age-related organ failure is also rising, thereby driving the market growth. As per the latest report published by Asian Development Bank, individuals aged 60 and above is expected to reach 1.3 billion by 2050 in the Asia-Pacific region. With such rise in the number of older individuals the demand for organ transplant testing is on a rise, driven by the increased prevalence of age-related organ failures and the need for precise, effective transplant solutions.

Moreover, the high-quality health infrastructure in this region drives the demand for transplant diagnostics by providing access to advanced transplant procedures and through pre-transplant screening. This infrastructure not only raises the number of transplants performed but also improves care before and after the procedures. According to a report published by the National Health Library in May 2023, China comprises of 36,750 hospitals and 977,790 primary clinics. The huge number of hospitals present in this region drives the demand for advanced treatment facility, thereby fuelling the transplant diagnostic market growth.

Competitive Landscape

Various market players operating in the transplant diagnostic industry are Abbott Laboratories, Thermo Fisher Scientific, Qiagen NV, Adaptive Biotechnologies Corporation, Hologic Inc., NanoString Technologies, Inc., Horiba, Ltd., Arquer Diagnostics Ltd., Eurofins Viracor Inc., CareDx Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Takara Bio Inc., and others. These companies are adopting various strategies such as product launches and collaborations to remain dominant in the market. 

For instance, in May 2024, Thermo Fisher Scientific announced to launch CXCL10 testing service, designed to aid in the management of kidney transplant patients, that provides information faster than current used tests. The testing service is expected to potentially make post-transplant care more convenient and less invasive for the patience living with a kidney transplant. 

Moreover, in April 2023, Care Dx partnered with Miromatrix to advance its research using bioengineered organs for human transplantation. This partnership allows Care Dx to accelerate their momentum as they drive the next wave of innovation with bioengineered alternatives for use in human organ transplants.

Also in January 2022, Thermo Fisher Scientific partnered with Olaris, a precision medicine company to assess the risk of complications from overimmunosuppression in kidney transplant recipients, this treatment is required to prevent a patient immune system.

Key Benefits

• The report provides quantitative analysis and estimations of the transplant diagnostic market from 2025 to 2030, which assists in identifying the prevailing market opportunities.

• The study comprises a deep-dive analysis of the current and future transplant diagnostic market trends to depict prevalent investment pockets in the industry.

• Information related to key drivers, restraints, and opportunities and their impact on the transplant diagnostic market is provided in the report. 

• Competitive analysis of the players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

Transplant Diagnostic Market Key Segments

By Product Type

• Transplant Diagnostic Instrument

• Transplant Diagnostic Software

• Transplant Diagnostic Reagent

By Technology

• PCR-Based Molecular Assays

• Sequencing Based Molecular Assays

By Transplant Type

• Solid Organ Transplantation

• Stem Cell Transplantation

• Soft Tissue Transplantation

• Bone Marrow Transplantation

• Others

By Application

• Diagnostic Application

• Research Application

By Distribution Channel

• Direct Tenders

• Retail Sales

• Others

By End-User

• Research Laboratories and Academic Institutes

• Hospital and Transplant Centers

• Commercial Service Providers

• Others

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The U.K.

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia

  • Rest of Europe

• Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia-Pacific 

• RoW

  • Latin America

  • Middle East 

  • Africa

Key Players

• Abbott Laboratories

• Thermo Fisher Scientific

• Qiagen NV

• Adaptive Biotechnologies Corporation

• Hologic Inc.

• NanoString Technologies, Inc.

• Horiba, Ltd.

• Arquer Diagnostics Ltd.

• Eurofins Viracor Inc.

• CareDx Inc.

• Becton, Dickinson and Company

• Bio-Rad Laboratories, Inc.

• F. Hoffmann-La Roche Ltd

• Illumina, Inc.

• Takara Bio Inc.

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Market Size in 2024	USD 4.59 billion
Revenue Forecast in 2030	USD 6.93 billion
Growth Rate	CAGR of 7.1% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Billion (USD)
Growth Factors	The increasing chronic diseases boosts the growth of transplant diagnostic industry. The technological advancements fuel the market growth for transplant diagnostics. The increasing ageing population worldwide is further fueling the growth of the market.
Countries Covered	28
Companies Profiled	15
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent to up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.